Melanoma 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Melanoma trials.

Effective solutions for advancing Melanoma research

Melanoma rates are increasing, particularly in young people. Its propensity to spread to other organs makes it the deadliest of all skin cancers. While advances in combination therapy are encouraging, there is still much work to be done. Signant SmartSignals solutions can generate reliable evidence while improving the clinical trial experience for patients everywhere.

Melanoma-1

Why Signant Health

  • Conduct Multi-Person Meetings
  • Collect Accurate Data
  • Simplify Consent & Reconsent
  • Gain Richer Insights
  • Optimize Supply Management
  • Conduct Multi-Person Meetings

    Conduct Multi-Person Meetings

    Signant’s Telemedicine solution is a secure, virtual platform that enables multi-person meetings, allowing you to add other specialists or caregivers. The digital tool can replace visits that do not require in-person evaluations with convenient, at-home meetings. The technology’s screen-sharing capabilities even allow you to annotate on top of medical images to improve patient comprehension.
     

  • Collect Accurate Data

    Collect Accurate Data

    Signant’s eCOA solution features a library of pre-built, disease-specific questionnaires. The digital platform collects real-time insights into the patients’ symptoms, satisfaction with the treatment, as well as the treatment’s effect on their quality of life. Unlike with paper-based methods, eCOA generates logical, attributable, and accurate data.
     

  • Simplify Consent & Reconsent

    Simplify Consent & Reconsent

    Choose any of our tiered eConsent solutions to help convey complex information about the disease and study to patients. The solution lets patients flag sections that require further clarification and checks their comprehension for a truly informed consent. It also manages the multiple consents common in oncology studies, ensuring the correct forms are always completed.
     

  • Gain Richer Insights

    Gain Richer Insights

    Integrate our eCOA with Actigraph sensors and wearables to stream a continuous, real-time view of each patients’ health status directly to the study teams. The objective data on sleep and activity patterns will enable enhanced insights into the post-treatment recovery.

  • Optimize Supply Management

    Optimize Supply Management

    Randomization & Trial Supply Management (RTSM) handles the multiple cohorts and combined medications involved in melanoma research with ease. Its proprietary algorithms intelligently direct the supplies only where they’re needed.

Comprehensive Melanoma experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Melanoma trial resources
SOLUTION BROCHURE

Melanoma Trial Solutions Overview


GET INSIGHTS
VIDEO

Melanoma Trial Solutions



WATCH [2 MIN]
SOLUTION

Oncology Clinical Trial Solutions

 
LEARN MORE

Ready to learn more?

Discover how Signant can support your current or upcoming melanoma trials.